Analyses of expression of phosphorylated Chk1, phosphorylated Chk2 and autophosphorylated forms for ATM, DNA-PKcs and ATR may provide further insights into the clinicopathological significance of the DNA damage signalling pathways in ovarian cancers. The gene discussed is CHEK1; the disease is ovarian carcinoma.